- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05486780
The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients
The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This research will be carried out as a randomized controlled experimental study to investigate the effect of the digital window on day and night perception status and sleep quality in intensive care patients. The research population consists of patients who underwent CABG and heart valve surgery and were admitted to the CVC ICU of Ankara Training and Research Hospital.
Sample size calculation
In order to calculate the sample size, a pilot study was conducted with 6 patients, three in the experimental group and three in the control group, and these pilot study data were used. As a result of the power analysis made with the help of the G*Power 3.0.10 program, the power of the study was found to be 80% for 2 groups and 3 repetitive study designs with an f=0.20 effect size and 5% margin of error. As a result, at least 42 samples in total, 21 of which were in the experimental group and 21 in the control group, were found to be sufficient. Considering that the sample size obtained is the lowest limit and the patients have the possibility of going into delirium under intensive care conditions or giving up on continuing to work afterward, considering that the losses may be high, 15% of the number determined according to the sampling calculation was calculated and 48 patients who met the criteria for inclusion in the study were sampled. In experimental studies, it is recommended that the sample loss should not be more than 10-15%.
Randomization
A simple randomization method will be used in the study, provided that there are equal numbers of male and female patients in the experimental and control groups, regardless of the age of the patients. Whether the first female and first male patients who will come at the beginning of the study will be in the experimental group or the control group will be determined by drawing lots. The following patients will be divided into two groups, according to the order of arrival, the same-sex patients in the experimental group and the control group.
Data collection tools: The data in the research; Patient Information Form, Richard-Campbell Sleep Questionnaire_RCSQ will be collected using the Day and Night Perception Form.
Research Implementation
Whether the first female and first male patients to come to the CVS ICU on the day of surgery will be the experimental group or the control group will be determined by drawing lots. The following patients will be divided into two groups, according to the order of arrival, same-sex patients in the experimental group and the control group. In this way, it is planned to establish a balance between the groups according to gender. The patients who will be assigned to the experimental group will sleep on the 1st, 2nd, and 3rd beds, and the patients who will be assigned to the control group will sleep in the 4th, 5th, and 6th beds. Data collection will be completed by the researcher by completing the Day and Night Perception Form and the Richards Campbell Sleep Scale (Post-Test) on the 1st, 2nd and 3rd days of post-op for the patients in the experimental group who are in the field of view of the digital window and the patients in the control group who are not in the field of view of the digital window. Night and Day Perception Form will be administered twice a day, once in the morning and in the evening, and Richards Campbell Sleep Scale will be administered once in the morning to each patient at the same time interval.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: İlkbal Bezek, Master Student
- Phone Number: +90 537 477 49 27
- Email: ilkbalbezek@gmail.com
Study Locations
-
-
Altındag
-
Ankara, Altındag, Turkey, 06230
- Ankara Training and Research Hospital-Cardiovascular Surgery Intensive Care Unit
-
Contact:
- Nigar Unlusoy Dincer, RN, PhD, Assistant Proffessor
- Phone Number: +90 533 653 19 39
- Email: nigardincer@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient has CABG and heart valve surgery
- The patient's willingness to participate in the study voluntarily
- Patient's ability to answer research questions
- The patient's age range is 19-79
- Being in the post-op period and staying in the ICU for at least 48 hours after the post-op period
- Determined as a Glasgow Coma Scale (GCS) score of 9 or higher
Exclusion Criteria:
- Patient undergoing another operation other than CABG and heart valve surgery
- The patient is intubated
- The patient's use of sedating drugs
- The patient is in delirium
- Patient's age other than 19-79
- Staying in the ICU for less than 48 hours after the post-op period
- Determined as GKS score below 9
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Digital window
The patients who will be assigned to the experimental group will sleep on the 1st, 2nd, and 3rd beds.
Experimental group patients are in the field of view of the digital window.
A digital window is a tool designed by the researcher to enable patients to differentiate between day and night.
|
For the digital window, a regal brand, 43R654FC, 43-inch (109 cm) television was used.
A three-dimensional frame was built to give the appearance of a window around the television.
For the digital window, a regal brand, 43R654FC, 43-inch (109 cm) television was used.
A three-dimensional frame was built to give the appearance of a window around the television.
Data collection will be completed by the researcher completing the Day and Night Perception Form and the Richards Campbell Sleep Scale (Post-Test) on the 1st, 2nd, and 3rd days of post-op for the patients in the experimental group who are in the field of view of the digital window.
|
No Intervention: Control group
the patients who will be assigned to the control group will sleep in the 4th, 5th, and 6th beds.
Control group patients are not in the field of view of the digital window.
Data collection will be completed by the researcher by completing the Day and Night Perception Form and the Richards Campbell Sleep Scale (Post-Test) on the 1st, 2nd, and 3rd days of post-op for the patients in the control group who are not in the field of view of the digital window.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
1.Change in sleep quality
Time Frame: Baseline measurements (Pre-op), at the post-op 1., 2. and 3. days after the completion of the interventions
|
Sleep quality will be measured based on the patient report by Richard-Campbell Sleep Questionnaire.
A higher score means an increase in sleep quality.
|
Baseline measurements (Pre-op), at the post-op 1., 2. and 3. days after the completion of the interventions
|
2. Change in day and night perception status
Time Frame: Measurements at the post-op 1., 2. and 3. days after the completion of the interventions
|
Day and night perception status will be measured based on the patient report byDay and Night Perception Form.
|
Measurements at the post-op 1., 2. and 3. days after the completion of the interventions
|
Collaborators and Investigators
Investigators
- Principal Investigator: İlkbal Bezek, Master Student, Ankara Yildirim Beyazıt University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ilkbal-dw
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Assistance Publique Hopitaux De MarseilleSuspendedAortic Valve Regurgitation AcquiredFrance
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
-
Caisson Interventional LLCActive, not recruitingMitral Regurgitation | Valve Disease, Heart | Valve Heart Disease | Mitral Valve Disease | Mitral Valve Failure | Mitral DiseaseUnited States
-
UMC UtrechtLeiden University Medical Center; The Interuniversity Cardiology Institute... and other collaboratorsTerminatedMitral Valve Insufficiency | Diseases of Mitral Valve | Heart; Disease, Mitral(Valve)Netherlands
-
Edwards LifesciencesRecruitingCardiovascular Diseases | Heart Failure | Heart Valve Diseases | Tricuspid Valve Regurgitation | Tricuspid Valve Insufficiency | Tricuspid Valve DiseaseUnited States, Germany
-
Synecor, LLCUnknownHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Disease
-
Edwards LifesciencesActive, not recruitingHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve DiseaseUnited States, Australia, Brazil
-
Universitätsklinikum Hamburg-EppendorfRecruitingAortic Valve Disease | Heart Valve Diseases | Mitral Valve Disease | Tricuspid Valve DiseaseGermany
-
Astana Medical UniversityCompletedMitral Valve Insufficiency | Aortic Valve InsufficiencyKazakhstan
Clinical Trials on Digital Window
-
University Hospital OlomoucJagiellonian University; University Hospital, GhentUnknownImpacted CanineBelgium, Poland, Czech Republic
-
Molnlycke Health Care ABCompletedPressure UlcerUnited Kingdom
-
University of California, DavisActive, not recruiting
-
Hams Hamed AbdelrahmanCompleted
-
Odense University HospitalUnknownHearing Loss | Deafness | Sensorineural Hearing LossDenmark
-
Universidad de MurciaRecruitingBone Loss | Surgical Procedure, Unspecified | Bone Loss, Age-related | Atrophy; Alveolar ProcessSpain
-
Tanta UniversityCompletedOroantral Fistula | Displaced ToothEgypt
-
University of Cape TownMedical Research Council, South AfricaCompletedHeart InjuriesSouth Africa
-
Federal University of Rio Grande do SulRecruiting
-
Henry Ford Health SystemAnalogic CorporationCompletedArteriovenous Fistula, CannulationUnited States